Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

7 projects found matching your search criteria :

  1. Identification of cytochrome P450 isoenzymes involved in the metabolism of levomepromazine in the human

    Call: OPUS 1 , Panel: NZ4

    Principal investigator: dr hab. Jacek Wójcikowski

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  2. The effect of typical and atypical neuroleptics on the expression of cytochrome P450 isoenzymes 1A2 (CYP1A2) and 3A4 (CY...

    Call: PRELUDIUM 8 , Panel: NZ7

    Principal investigator: Agnieszka Basińska-Ziobroń

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  3. The effect of the novel atypical neuroleptics on the activity and expression of cytochrome P450 isoforms in human liver

    Call: OPUS 6 , Panel: NZ7

    Principal investigator: dr hab. Jacek Wójcikowski

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  4. Studies on the mechanism regulating expression of hormone-dependent cytochromes P450 in the rat liver under conditions o...

    Call: PRELUDIUM 4 , Panel: NZ4

    Principal investigator: Rafał Andrzej Skowronek

    Śląski Uniwersytet Medyczny w Katowicach, Wydział Lekarski w Katowicach

  5. The influence of the serotonergic system on the regulation of liver CYP activity in hepatocellular carcinoma

    Call: SONATA 4 , Panel: NZ4

    Principal investigator: dr Marta Ewa Kot

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  6. The effect of prolonged treatment with the new antipsychotics brexpiprazole and lumateperone on human liver function usi...

    Call: OPUS 26 , Panel: NZ4

    Principal investigator: dr Przemysław Jan Danek

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  7. Brain cytochrome P450 as a new target for the treatment of neurological and psychiatric diseases. Studies with human neu...

    Call: OPUS 23 , Panel: NZ7

    Principal investigator: prof. Władysława Anna Daniel

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk